T36.2 Poisoning by, adverse effect of and underdosing of chloramphenicol group

Name of the Condition

• Poisoning by, adverse effect of and underdosing of chloramphenicol group

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to chloramphenicol and its derivatives. It includes cases where exposure to this antibiotic group leads to harmful effects, unintended reactions, or insufficient therapeutic levels. Documentation should specify the type of chloramphenicol, intent (e.g., accidental, therapeutic error), and encounter details.

Causes

Poisoning or adverse effects may result from accidental or intentional overdose of chloramphenicol, incorrect administration, or allergic reactions. Underdosing occurs when therapeutic levels are not achieved, often due to dosing errors, non-adherence, or inadequate prescription. Adverse effects can stem from drug interactions, idiosyncratic reactions, or cumulative toxicity.

Risk Factors

• Prior history of antibiotic allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., hematologic effects like bone marrow suppression).
• Underdosing: Persistent infection, treatment failure.

Diagnosis

Evaluation includes patient history of chloramphenicol use, clinical assessment of symptoms, and laboratory tests to detect drug levels or adverse effects (e.g., blood counts for bone marrow suppression). Documentation must clarify the nature of the event (poisoning, adverse effect, or underdosing) to guide coding.

Treatment Options

Management depends on the event type: poisoning may require decontamination or supportive care; adverse effects may involve discontinuing the drug and treating symptoms; underdosing may necessitate dose adjustment or re-education on adherence. Specific interventions are tailored to clinical presentation.

Prognosis and Follow-Up

Prognosis varies by severity and timely intervention. Underdosing may lead to treatment failure, while adverse effects like bone marrow suppression require monitoring. Follow-up includes assessing resolution of symptoms, drug level checks, and adjusting therapy as needed.

Complications

Severe cases may result in organ damage (e.g., hematologic toxicity), treatment-resistant infections from underdosing, or life-threatening allergic reactions. Long-term complications depend on the extent of exposure and response to treatment.

Lifestyle & Prevention

• Educate patients on proper medication use and adherence.
• Avoid self-medication or sharing antibiotics.
• Monitor for signs of adverse reactions and report promptly.
• Ensure prescriptions are clear and dosing is appropriate for patient factors (e.g., age, organ function).

When to Seek Professional Help

Seek care if experiencing severe symptoms (e.g., anaphylaxis, persistent fever, unusual bleeding), signs of infection worsening, or suspected overdose. Immediate medical attention is critical for life-threatening reactions.

Tips for Medical Coders

Document the specific chloramphenicol agent, intent (accidental/intentional), and event type (poisoning/adverse effect/underdosing) to ensure accurate coding. Clarify encounter details (e.g., inpatient vs. outpatient) and any contributing factors (e.g., dosing errors, non-adherence) for comprehensive coding.